Home › Therapeutic areas › Metabolic › Prader-Willi Syndrome
Prader-Willi Syndrome (5 companies)
Companies with an active program in Prader-Willi Syndrome.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| AARD | Aardvark Therapeutics | DermatologyMetabolic+1 Rare | 1 | Phase 3 | $25.6M | 3 |
| HRMY | Harmony Biosciences | MetabolicNeurology Rare | 2 | Approved | $1.94B | 17 |
| PTN | Palatin Technologies | ImmunologyMetabolic+1 Rare | 1 | Phase 3 | $11.2M | 8 |
| RLMD | Relmada Therapeutics | MetabolicNeurology+1 Rare | 1 | Phase 2 | $416M | 4 |
| RYTM | Rhythm Pharmaceuticals | Metabolic Rare | 3 | Approved | $7.78B | 14 |
No companies match.